PT  - JOURNAL ARTICLE
AU  - Maffei, Chiara
AU  - Gilmore, Natalie
AU  - Snider, Samuel B.
AU  - Foulkes, Andrea S.
AU  - Bodien, Yelena G.
AU  - Yendiki, Anastasia
AU  - Edlow, Brian L.
TI  - Automated detection of axonal damage along white matter tracts in acute severe traumatic brain injury
AID  - 10.1101/2022.03.09.22271989
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.09.22271989
4099  - http://medrxiv.org/content/early/2022/06/29/2022.03.09.22271989.short
4100  - http://medrxiv.org/content/early/2022/06/29/2022.03.09.22271989.full
AB  - New techniques for individualized assessment of white matter integrity are needed to detect traumatic axonal injury (TAI) and predict outcomes in critically ill patients with acute severe traumatic brain injury (TBI). Diffusion MRI tractography has the potential to quantify white matter microstructure in vivo and has been used to characterize tract-specific changes following TBI. However, tractography is not routinely used in the clinical setting to assess the extent of TAI, in part because focal lesions reduce the robustness of automated methods. Here, we propose a pipeline that combines automated tractography reconstructions of 40 white matter tracts with multivariate analysis of along-tract diffusion metrics to assess the presence of TAI in individual patients with acute severe TBI. We used the Mahalanobis distance to identify abnormal white matter tracts in each of 18 patients with acute severe TBI as compared to 33 healthy subjects. In all patients for which a FreeSurfer anatomical segmentation could be obtained (17 of 18 patients), including 13 with focal lesions, the automated pipeline successfully reconstructed a mean of 37.5 +/- 2.1 white matter tracts without the need for manual intervention. A mean of 2.5 +/- 2.1 tracts resulted in partial or failed reconstructions and needed to be reinitialized upon visual inspection. The pipeline detected at least one abnormal tract in all patients (mean: 9.07 +/- 7.91) and could accurately discriminate between patients and controls (AUC: 0.91). The individual patients’ profiles showed the number and neuroanatomic location of abnormal tracts varied across patients and levels of consciousness. The premotor, temporal, and parietal sections of the corpus callosum were the most commonly damaged tracts (in 10, 9, and 8 patients respectively), consistent with histological studies of TAI. TAI measures were not associated with concurrent behavioral measures of consciousness. In summary, we provide proof-of-principle evidence that an automated tractography pipeline has translational potential to detect and quantify TAI in individual patients with acute severe traumatic brain injury.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the U.S. Department of Defense (USSOCOM Contract No. H9240520D0001), NIH National Institute of Neurological Disorders and Stroke (R01NS119911, R21NS109627, RF1NS115268, U01NS1365885, U01NS086090), NIH Director's Office (DP2 HD101400), NIH National Institute of Biomedical Imaging and Bioengineering (R01EB021265, U01EB026996), NIH National Institute of Mental Health (U01MH108168, R56MH121426), James S. McDonnell Foundation, American Academy of Neurology, Tiny Blue Dot Foundation, and National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Administration for Community Living (90DPCP0008-01-00, 90DP0039).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Mass General Brigham Institutional Review Board of Massachusetts General Hospital gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe TRACULA version and the training dataset are included in FreeSurfer 7.2 (https://github.com/freesurfer/freesurfer/tree/fs-7.2). Extensive documentation and tutorials are available on the FreeSurfer wiki (https://surfer.nmr.mgh.harvard.edu/fswiki/Tracula). Part of the raw DWI data are available at https://openneuro.org/datasets/ds003367/versions/1.0.0. All remaining DWI data produced in the present study are available upon request to the authors. https://openneuro.org/datasets/ds003367/versions/1.0.0